ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Corium International, Inc.
12.68
0.0000
成交量:
- -
成交额:
- -
市值:
4.63亿
市盈率:
-8.20
高:
12.68
开:
12.68
低:
12.68
收:
12.68
52周最高:
13.93
52周最低:
7.17
股本:
3,651.78万
流通股本:
923.00万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-1.5461
每股收益(LYR):
-1.6440
净资产收益率:
--
总资产收益率:
--
市净率:
18.60
市盈率(LYR):
-7.71
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
Corium International, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.coriumgroup.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Corium International, Inc.于1995年成立于密歇根州,也叫Corium公司并于1996年成为Converting Systems公司。 Corium International是一种商业化阶段的生物制药公司,利用其在透皮和粘膜给药系统的丰富经验,专注于开发,制造及专业制药产品的商业化。再加上Corium International的合作伙伴,该公司已在处方药和消费市场成功开发出六大销售产品,而Corium International是为公司的营销合作伙伴提供产品的唯一商业供应商。这些销售的产品是可乐定透皮缓释系统 (或TDS ),芬太尼TDS和四个先进的密封白牙产品。Corium International以显著的机会使用其新颖透皮和粘膜的方法来将新产品推向市场。Corium International的开发平台,使透皮递送大分子或生物制剂,包括疫苗,肽和蛋白质以及小分子,否则很难以透皮剂的形式传输。Corium International的传递途径包括给美国食品和药物管理局(FDA)的未决药品营销应用。此外,Corium International有12个合作伙伴,和在早期阶段自筹资金的项目。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠:港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CORI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CORI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","market":"US","secType":"STK","nameCN":"Corium International, Inc.","latestPrice":12.68,"timestamp":1557518400000,"preClose":12.68,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":9230000,"shares":36517802,"eps":-1.546149,"marketStatus":"停牌","change":0,"latestTime":"03-23 11:44:56 EDT","open":12.68,"high":12.68,"low":12.68,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.546149,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1396497600000,"exchange":"NASDAQ","adjPreClose":12.68,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","floatShares":9230000,"roa":"--","roe":"--","lyrEps":-1.644018,"shares":36517802,"dividePrice":0,"high":12.68,"amplitude":0,"preClose":12.68,"low":12.68,"week52Low":7.17,"pbRate":"18.60","week52High":13.93,"institutionHeld":0,"latestPrice":12.68,"eps":-1.546149,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.546149,"open":12.68,"prevYearClose":12.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-08-09","symbol":"CORI","fiscalQuarterEnding":"2018/06","expectedEps":-0.39,"name":null,"time":"盘后","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2018-05-14","symbol":"CORI","fiscalQuarterEnding":"2018/03","expectedEps":-0.41,"name":null,"time":"盘后","type":"earning","dateTimestamp":1526270400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2018-02-08","symbol":"CORI","fiscalQuarterEnding":"2017/12","expectedEps":-0.43,"name":null,"time":"盘后","type":"earning","dateTimestamp":1518066000000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2017-11-16","symbol":"CORI","fiscalQuarterEnding":"2017/09","expectedEps":-0.43,"name":null,"time":"盘后","type":"earning","dateTimestamp":1510808400000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2017-08-03","symbol":"CORI","fiscalQuarterEnding":"2017/06","expectedEps":-0.3,"name":null,"time":"盘后","type":"earning","dateTimestamp":1501732800000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.coriumgroup.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corium International, Inc.于1995年成立于密歇根州,也叫Corium公司并于1996年成为Converting Systems公司。 Corium International是一种商业化阶段的生物制药公司,利用其在透皮和粘膜给药系统的丰富经验,专注于开发,制造及专业制药产品的商业化。再加上Corium International的合作伙伴,该公司已在处方药和消费市场成功开发出六大销售产品,而Corium International是为公司的营销合作伙伴提供产品的唯一商业供应商。这些销售的产品是可乐定透皮缓释系统 (或TDS ),芬太尼TDS和四个先进的密封白牙产品。Corium International以显著的机会使用其新颖透皮和粘膜的方法来将新产品推向市场。Corium International的开发平台,使透皮递送大分子或生物制剂,包括疫苗,肽和蛋白质以及小分子,否则很难以透皮剂的形式传输。Corium International的传递途径包括给美国食品和药物管理局(FDA)的未决药品营销应用。此外,Corium International有12个合作伙伴,和在早期阶段自筹资金的项目。","exchange":"NASDAQ","name":"Corium International, Inc.","nameEN":"Corium"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":null}}